Restasis 0.05% ophthalmic emulsion multidose Images
Generic Name: cyclosporine
This medication has been identified as Restasis 0.05% ophthalmic emulsion multidose. It is supplied by Allergan plc.
Restasis is used in the treatment of Dry Eye Disease and belongs to the drug class ophthalmic anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Restasis 0.05% ophthalmic emulsion multidose is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Restasis
- Generic Name
- cyclosporine
- Strength
- 0.05% ophthalmic emulsion multidose
- Availability
- Prescription only
- Drug Class
- Ophthalmic anti-inflammatory agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Allergan plc
- National Drug Code (NDC)
- 00023-5301
More about Restasis (cyclosporine ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (218)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Support group
- Drug class: ophthalmic anti-inflammatory agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.